B
ISEE

Braidwell’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Braidwell’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,714,672
Closed -$90.4M – 94
2023
Q1 		$90.4M Buy
3,714,672
+373,372
+11% +$8.17M 2.98% 9
2022
Q4 		$71.5M Buy
+3,341,300
New +$71.3M 2.4% 8

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Braidwell's ISEE Position: Q2 2023 in Review

Braidwell sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 3,714,672 shares — an estimated $90.4M sold.

Braidwell first reported a position in ISEE in Q4 2022 and held it in 2 quarters. The position peaked at $90.4M in Q1 2023. 255 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Braidwell reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Braidwell sold 3,714,672 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $90.4M.
  • Braidwell first reported a position in IVERIC bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Braidwell's IVERIC bio, Inc. Common Stock position peaked at $90.4M in Q1 2023.
  • 255 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Braidwell's 13F filing for Q2 2023, filed 14 Aug 2023.